MEETING VENUE
Marmara Taksim Hotel. Istanbul, Turkey
DATE
27th – 28th June 2019
SPEAKERS
SEATS
150-200
Organized by:
Scientific Secretariat:
Technical Secretariat:
Marmara Taksim Hotel. Istanbul, Turkey
27th – 28th June 2019
150-200
Ingrid Bistervels (1989), MD, qualified as a medical doctor at the University of Amsterdam, the Netherlands, in 2015. She worked as a clinical doctor at the department of Internal Medicine at the Flevoziekenhuis in Almere year before she got involved in research.
Since April 2016 she is a PhD candidate supervised by Professor Saskia Middeldorp at the department of Vascular Medicine at the Academic Medical Center in Amsterdam. Her main fields of interest are pregnancy & thrombosis, women’s issues in the field thrombosis and long-term outcomes of VTE.
Dr Elvira Grandone, MD, is a Board certified Obstetrician and Gynaecologist with over 25 years of extensive experience in the field of molecular biology and genetics. Dr Grandone has conducted many clinical research trials serving as principal or local investigator. She has been involved in the compilation of guidelines and consensus conferences.
Dr. Grandone is Medical Director of the Hemostasis and Thrombosis Department, at the Institute “IRCCS Ospedale Casa Sollievo della Sofferenza”, at San Giovanni Rotondo, Foggia.
She is in the Executive Committee of the Italian Society of Thrombosis and Haemostasis and is member of the review board meeting in Mainz (Germany) for the “Integrated Research and Treatment Centers-IFB” (FUNDING BY THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH”).
Her research interests include: thrombophilia, venous thrombosis, pregnancy complications, genetic predisposition to multifactorial diseases, somatic mutations involved in the development of myeloproliferative neoplasms, genetic studies on rare bleeding disorders.
Recent Research Interests:
Research of new risk factors for pregnancy complications/venous thromboembolism and investigation of placentae from women with adverse obstetric outcomes (mainly studies of gene expression). Recent original data have been obtained in the field of annexin A5.
Many collaborations with national Centres of excellence for the diagnosis and treatment of thrombosis and haemorrhage are currently under way, as shown by many papers published.
He worked as consultant for urgent vascular surgery at the clinical doctor at the department of Internal Medicine at the Center of Disaster Medicine of Latvia for 5 years.
Since 2008 he works as vascular surgeon for out–patients at Pauls Stradins CUH and simultaneously from 2009 works also as vascular surgeon and phlebologist at Dr. Mauriņš Vein center located in Riga.
He has published several articles, presented oral and written communications at congressed related with his field.
Dr. Rits is member of the Latvian Society for vascular surgeons since 2003 and junior member of European Society for vascular surgery since 2004.
Professor Ingrid Pabinger is currently Professor of Haemostaseology at the Medical University Vienna, Vienna, Austria and Deputy Head of the Division of Hematology and Blood Coagulation and Head of the Coagulation Clinic at Vienna General Hospital.
Professor Pabinger’s clinical and scientific focus is in the field of coagulation disorders in both patients with hemophilia and idiopathic thrombocytopenic purpura, as well as those with thrombosis. Professor Pabinger has published over 390 peer-reviewed papers in the fields of thrombosis and haemostasis, hematology and internal medicine. She is a member of several international and national societies and is presently the Chair of the International Society on Thrombosis and Haemostasis (ISTH) Council.
She received her MD degree from the Medical School of National and Capodistrian University of Athens. She specialized in Haematology at University Hospital of Patras, where she acquired her PhD title. She has a long experience in haemostasis having an active role in the organization of the “Hematology and Anticoagulation Outpatient Clinic” in “KAT” General Hospital of Athens and ATTIKON University Hospital.
Since 2012 she is Head of Transfusion Service of “Saint Savvas” Oncology Hospital of Athens while she is responsible of the “Outpatient Clinic of Hemostasis Disorders”, in which patients with thrombotic and hemorrhagic disorders mainly with cancer, as well as pregnant women with thrombotic complications and abortions are monitored.
Professor Llau is anaesthesiologist and Head of Service of Anaesthesia and Post-Surgical Critical Care at Doctor Peset University Hospital in Valencia, Spain, and is Associated Professor of Human Physiology at the University of Valencia.
He received his medical degree in Valencia, Spain, in 1986, where he studied anaesthesiology at the Hospital La Fe, becoming an anaesthesiologist in 1993. His research interests are thrombosis and hemostasis, fluidtherapy and transfusion practice.
He is a member of several Spanish and International groups involved in the study of transfusion practice and hemostasis management. He is also a member of the board of examiners for the ESA European Diploma of Anaesthesiology.
Professor Llau has been the founder of the Transfusion and Haemostasis group of the Spanish Society of Anaesthesiology. He has published over 150 papers and book chapters related to transfusion practice and thrombosis and hemostasis, belonging to the Task Force of “Perioperative Bleeding Management” and “Perioperative Thromboprophylaxis” of the European Society of Anaesthesiology. He is the editor of five books on transfusion and haemostasis medicine.
Dr. Juan Ignacio Arcelus is Professor and Chairman of the Department of Surgery at Granada Medical School University and attending surgeon in the Service of General Surgery at the Virgen de las Nieves University Hospital, Granada, Spain.
His main research interests include the epidemiology, diagnosis, prevention, treatment, and follow-up of venous thromboembolism (VTE) in medical and surgical patients.
For the past 15 years, he has been involved in the RIETE registry. He is also patron of the Spanish Foundation for the Study of Thromboembolism (FUENTE). A member of numerous societies and the Royal Academy of Medicine in Granada, Dr. Arcelus has presented more than 300 abstracts and lectures to international meetings, published more than 100 papers in peer-reviewed journals, and has written 28 book chapters. He has been panelist in the latest American College of Chest Physicians (ACCP) Guidelines for Antithrombotic and Thrombolytic Therapy and the American Society of Clinical Oncology (ASCO) guidelines on prevention and treatment of venous thromboembolism in cancer patients.
Prof. Paolo Prandoni was born in 1947, and reached his graduation at the Faculty of Medicine of the University of Padua in 1971. He defended his PhD thesis at Amsterdam University in 1992. He became Associate Professor of Internal Medicine in 2000, and Full Professor of Internal Medicine in 2006.
His scientific interest has been mainly involved in studies addressing epidemiology, pathogenesis, diagnosis, prevention, treatment and follow-up of venous thromboembolism. His scientific activity is documented by almost 500 articles “in extenso” in high-impact scientific medical journals.
Training in Haematology at Fundación Jiménez Díaz, University Autónoma Madrid 1976-1980. Hematology Consultant at Ramón y Cajal Hospital in Madrid until 1993. Head of Hematology Department. Río Hortega University Hospital. Professor of Hematology in University of Valladolid.
Research formation in the Department of Haematology, Welsh National School of Medicine in Cardiff (1982), Blood Products Division, National Institute for Biological Standards and Control in London – United Kingdom (1985-1986). 182 articles published and 300 congress communications.